{"nctId":"NCT00487695","briefTitle":"Confocal Endomicroscopy for Barrett's Esophagus","startDateStruct":{"date":"2007-04"},"conditions":["Barrett's Esophagus","Esophageal Adenocarcinoma"],"count":46,"armGroups":[{"label":"CLE followed by standard EGD","type":"ACTIVE_COMPARATOR","interventionNames":["Device: confocal laser endomicroscopy (CLE)","Device: standard endoscopy (EGD)"]},{"label":"standard EGD followed by CLE","type":"ACTIVE_COMPARATOR","interventionNames":["Device: confocal laser endomicroscopy (CLE)","Device: standard endoscopy (EGD)"]}],"interventions":[{"name":"confocal laser endomicroscopy (CLE)","otherNames":["Pentax Confocal Laser Endomicroscope(EC3870KCILK)"]},{"name":"standard endoscopy (EGD)","otherNames":["Olympus upper endoscope (GIF160)"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Barrett's esophagus or suspected Barrett's-associated neoplasia\n* Age \\> 18\n* Able to give informed consent\n\nExclusion Criteria:\n\n* Known advanced malignant disease\n* Allergy to the fluorescent contrast agent fluorescein sodium\n* Coagulopathy or bleeding disorder","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Diagnostic Yield for Neoplasia in High Risk Patients(Suspected Neoplasia)","description":"The yield for neoplasia is calculated by the number of biopsies showing neoplasia over the total number of biopsies taken (normal + neoplastic biopsies)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"34","spread":"0"},{"groupId":"OG001","value":"17","spread":"0"}]}]}]},{"type":"SECONDARY","title":"Mean Number of Biopsies With Neoplasia in High Risk Patients (Suspected Neoplasia)","description":"The number of biopsies from each procedure (i.e. biopsies taken during CLE, or biopsies taken during standard EGD) that showed neoplasia. Neoplasia is high grade dysplasia or cancer. This analysis looks at patients with Barrett's suspected (but not known) neoplasia.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.1","spread":null},{"groupId":"OG001","value":"3.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Number of Biopsies Taken in High Risk Patients (Suspected Neoplasia)","description":"The number of biopsies taken during each procedure (i.e. the number of biopsies taken during CLE, or the number of biopsies taken during standard EGD). Biopsies are taken during CLE only if CLE shows that the esophageal mucosa is abnormal. Esophageal biopsies are taken during standard EGD using a standard Barrett's esophagus protocol (4 quadrants, every 1-2 cm of the Barrett's esophagus). This analysis looks at the Barrett's patients with suspected (but not known) neoplasia.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.8","spread":null},{"groupId":"OG001","value":"23.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Diagnostic Yield for Neoplasia in Barrett's Surveillance Patients","description":"Our hypothesis was that the yield for neoplasia would be higher using confocal laser endomicroscopy compared to standard endoscopy. The null hypothesis would be that there is no difference in yield for neoplasia when CLE is used compared to standard endoscopy. This analysis looks specifically at patients who were referred for surveillance of Barrett's esophagus (no suspected neoplasia).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Number of Biopsies With Neoplasia in Barrett's Surveillance Patients","description":"The number of biopsies from each procedure (i.e. biopsies taken during CLE, or biopsies taken during standard EGD) that showed neoplasia. Neoplasia is high grade dysplasia or cancer. This analysis looks at patients undergoing surveillance EGD for Barrett's esophagus (no suspected neoplasia).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Number of Biopsies Taken in Barrett's Surveillance Patients","description":"The number of biopsies taken during each procedure (i.e. the number of biopsies taken during CLE, or the number of biopsies taken during standard EGD). Biopsies are taken during CLE only if CLE shows that the esophageal mucosa is abnormal. Esophageal biopsies are taken during standard EGD using a standard Barrett's esophagus protocol (4 quadrants, every 1-2 cm of the Barrett's esophagus). This analysis looks at the patients with Barrett's esophagus in the study who were undergoing surveillance EGD (no suspected neoplasia).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":null},{"groupId":"OG001","value":"12.6","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":39},"commonTop":[]}}}